|
|
Consulting, Statistics, pharmaceutical and biotechnology |
|
|
Consulting |
|
|
Pharmaceutical Biotechnology |
|
|
Dr. Chen is a statistical consultant for the pharmaceutical and biotechnology industry. |
|
|
He dedicates himself to the ALS Association as a donor. |
|
|
He has been consulting for 24 years. |
|
|
He earned a Bachelor of Science in Mathematics from East China Normal University in 1982 and earned a Doctor of Philosophy in Mathematics from Texas Tech University in 1990. |
|
He is the author of the statistical section of many articles published in medical journals, including “Analysis of early hypertension and clinical outcome with Bevacizumab: Results from seven phase III studies,” Predictive Impact of Circulating Vascular Endothelial Growth Factor in Four Phase III Trials Evaluating Bevacizumab,” "Impact of Exploratory Biomarkers on the Treatment Effect of Bevacizumab in Metastatic Breast Cancer” and “Refractory Mucosal Candidiasis in Advanced Human Immunodeficiency Virus Infection”. |
|
|
He worked as a statistician for Gen-Probe, Quintiles, and Pharsight between 1996 and 2001. Before that, he taught at Texas Tech University and was a researcher at Harvard University. Currently, he is a statistical consultant for the pharmaceutical and biotechnology industry. |
|
|
Awards for Dr. Chen’s work include being named Best Teacher of the Year at Texas Tech University in 1988 and honored in Marquis Whos Who 2021. |
|
|
Looking towards the future, he plans to help his granddaughter excel in mathematics and statistics. |
